Status:
COMPLETED
Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol
Lead Sponsor:
GlaxoSmithKline
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Effect of inhaled drugs administered as dry powder is not only dependent on drug efficacy but also on technical properties of the inhalers. Different inhalers have different internal resistances and t...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Asthma Reversibility \>15% and 200 ml in total FEV1 \<85% of normal
- Exclusion criteria:
- Smoking history \>20 pack years Treatment with ICS \>500μg Fluticasone or aquivalent in the last 4 weeks Asthma exacerbation in the last 4 weeks
Exclusion
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00327353
Start Date
January 1 2004
Last Update
May 22 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Gauting, Bavaria, Germany, 82131
2
GSK Investigational Site
Berlin, State of Berlin, Germany, 14057